A1LN34:BVMF
Alnylam Pharmaceuticals Inc Bdr
R$ 59,40
0,00%
(0,00) 1D
15 de out., 16:56:00 GMT-3 · BRL
search
Todos os ativos
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para A1LN34…
Abrir
R$ 58,26
Alta
R$ 59,40
Baixa
R$ 58,26
Valor de mercado
31,32 bi
Volume médio
440,00
Volume
191,00
Alto — 52 sem
R$ 132,40
Baixo — 52 sem
R$ 50,25
Ações em circulação
133,81 mi
Nº de funcionários
2 mil
Abrir
R$ 58,26
Alta
R$ 59,40
Baixa
R$ 58,26
Valor de mercado
31,32 bi
Volume médio
440,00
Volume
191,00
Alto — 52 sem
R$ 132,40
Baixo — 52 sem
R$ 50,25
Ações em circulação
133,81 mi
Nº de funcionários
2 mil
Notícias
De fontes da web e parceiros de notícias
ad-hoc-news.de
·
há 17 horas
Citigroup cuts target to USD 320 for Alnylam Pharmaceuticals stock
BioSpace
·
há 23 horas
Alnylam to Webcast Conference Call Discussing Third Quarter 2026 Financial Results
BioSpace
·
há 2 dias
Alnylam bulls and bears fight it out after business-shaking guidance cut
The Globe and Mail
·
há 2 semanas
18 of 21 Analysts Still Think Alnylam Stock Is a Buy. Here's Why They're Right.
Perfil
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
Sobre Alnylam Pharmaceuticals Inc Bdr